MarginsXMarginsX
Home › Markets › Health Care › OM

Outset Medical Inc. (OM)

OM trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.39
-9.12% on the day
Market cap
$64.0M
Micro cap
Revenue · 2025
$119.5M
+5.1% on 2024
Net income · 2025
-$81.7M
-68.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1484612/000119312526051278/0001193125-26-051278-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerOM on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2020
SEC CIK0001484612
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$119.5M
Net income-$81.7M
Operating income-$66.7M
Net margin-68.3%
Operating margin-55.8%
Revenue growth+5.1%
Cash$35.0M
Total assets$264.5M
P/E (computed)Net income was not positive
P/S (computed)0.5×

Warning signs

Cash runway
9.6 months
$33.9M cash at September 30, 2026
Share count, 1 year
+4.0%
2025-11-06 to 2026-11-02 · +463.9% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$369K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$33.9M cash; operating cash flow -$10.6M a quarter.Report 2026-09-30
Shares outstanding18,872,597 (2026-11-02); 18,153,090 a year earlier; 50,204,570 three years earlier. 3y figure adjusted for split (1-for-15 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-15 on 2025-03-20Source 2025-03-20
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $369K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$33.6M-$14.7M-$10.4M$33.9M$98.4M$122.0M10-Q 2026-11-04
Q2 2026
2026-06-30
$31.6M-$18.0M-$9.6M$35.0M$97.6M$117.8M10-Q 2026-08-06
Q1 2026
2026-03-31
$27.9M-$19.0M-$12.8M$30.6M$96.9M$117.6M10-Q 2026-05-07
Q4 2025
2025-12-31
$28.9M-$19.5M-$9.5M$35.0M$96.2M$119.5M10-K 2026-02-13
Q3 2025
2025-09-30
$29.4M-$17.8M-$6.3M$36.4M$95.5M$120.1M10-Q 2026-11-04
Q2 2025
2025-06-30
$31.4M-$18.5M-$4.8M$39.6M$94.8M$119.3M10-Q 2026-08-06
Q1 2025
2025-03-31
$29.8M-$25.8M-$25.7M$75.9M$94.1M$115.3M10-Q 2026-05-07
Q4 2024
2024-12-31
$29.5M-$25.6M-$16.5M$124.0M$197.4M$113.7M10-K 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32025-02-28
Latest annual report10-K2026-02-13
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 746 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.8%
1 month-8.1%
3 months-12.2%
Year to date+0.5%
1 year-23.9%
From 52-week high-34.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
ECORelectroCore Inc.$4.84-7.81%$44.7M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier